vs

Side-by-side financial comparison of Dexcom (DXCM) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $934.8M, roughly 1.3× Sensata Technologies Holding plc). Dexcom runs the higher net margin — 21.2% vs 9.3%, a 11.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -5.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

DXCM vs ST — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$934.8M
ST
Growing faster (revenue YoY)
DXCM
DXCM
+19.0% gap
DXCM
21.6%
2.6%
ST
Higher net margin
DXCM
DXCM
11.9% more per $
DXCM
21.2%
9.3%
ST
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-5.0%
ST

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
ST
ST
Revenue
$1.3B
$934.8M
Net Profit
$267.3M
$87.1M
Gross Margin
62.9%
30.6%
Operating Margin
25.6%
15.1%
Net Margin
21.2%
9.3%
Revenue YoY
21.6%
2.6%
Net Profit YoY
153.6%
24.6%
EPS (diluted)
$0.67
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
ST
ST
Q1 26
$1.3B
$934.8M
Q4 25
$1.3B
$917.9M
Q3 25
$1.2B
$932.0M
Q2 25
$1.2B
$943.4M
Q1 25
$1.0B
$911.3M
Q4 24
$1.1B
$907.7M
Q3 24
$994.2M
$982.8M
Q2 24
$1.0B
$1.0B
Net Profit
DXCM
DXCM
ST
ST
Q1 26
$267.3M
$87.1M
Q4 25
$267.3M
$63.2M
Q3 25
$283.8M
$-162.5M
Q2 25
$179.8M
$60.7M
Q1 25
$105.4M
$69.9M
Q4 24
$151.7M
$5.8M
Q3 24
$134.6M
$-25.0M
Q2 24
$143.5M
$71.7M
Gross Margin
DXCM
DXCM
ST
ST
Q1 26
62.9%
30.6%
Q4 25
62.9%
29.0%
Q3 25
60.5%
27.8%
Q2 25
59.5%
30.3%
Q1 25
56.9%
29.9%
Q4 24
58.9%
27.1%
Q3 24
59.7%
28.6%
Q2 24
62.4%
30.0%
Operating Margin
DXCM
DXCM
ST
ST
Q1 26
25.6%
15.1%
Q4 25
25.6%
10.9%
Q3 25
20.1%
-13.2%
Q2 25
18.4%
14.6%
Q1 25
12.9%
13.4%
Q4 24
17.0%
8.1%
Q3 24
15.3%
-20.3%
Q2 24
15.7%
12.5%
Net Margin
DXCM
DXCM
ST
ST
Q1 26
21.2%
9.3%
Q4 25
21.2%
6.9%
Q3 25
23.5%
-17.4%
Q2 25
15.5%
6.4%
Q1 25
10.2%
7.7%
Q4 24
13.6%
0.6%
Q3 24
13.5%
-2.5%
Q2 24
14.3%
6.9%
EPS (diluted)
DXCM
DXCM
ST
ST
Q1 26
$0.67
$0.59
Q4 25
$0.67
$0.45
Q3 25
$0.70
$-1.12
Q2 25
$0.45
$0.41
Q1 25
$0.27
$0.47
Q4 24
$0.37
$0.05
Q3 24
$0.34
$-0.17
Q2 24
$0.35
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
ST
ST
Cash + ST InvestmentsLiquidity on hand
$917.7M
$635.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$2.9B
Total Assets
$6.3B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
ST
ST
Q1 26
$917.7M
$635.1M
Q4 25
$917.7M
$573.0M
Q3 25
$1.8B
$791.3M
Q2 25
$1.2B
$661.8M
Q1 25
$904.9M
$588.1M
Q4 24
$606.1M
$593.7M
Q3 24
$621.2M
$506.2M
Q2 24
$939.2M
$1.0B
Total Debt
DXCM
DXCM
ST
ST
Q1 26
Q4 25
$2.8B
Q3 25
Q2 25
Q1 25
Q4 24
$3.2B
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
ST
ST
Q1 26
$2.7B
$2.9B
Q4 25
$2.7B
$2.8B
Q3 25
$2.7B
$2.7B
Q2 25
$2.6B
$2.9B
Q1 25
$2.3B
$2.8B
Q4 24
$2.1B
$2.9B
Q3 24
$2.0B
$3.0B
Q2 24
$2.4B
$3.0B
Total Assets
DXCM
DXCM
ST
ST
Q1 26
$6.3B
$6.8B
Q4 25
$6.3B
$6.8B
Q3 25
$7.5B
$7.1B
Q2 25
$7.3B
$7.3B
Q1 25
$6.8B
$7.2B
Q4 24
$6.5B
$7.1B
Q3 24
$6.4B
$7.3B
Q2 24
$6.8B
$8.2B
Debt / Equity
DXCM
DXCM
ST
ST
Q1 26
Q4 25
1.02×
Q3 25
Q2 25
Q1 25
Q4 24
1.11×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
ST
ST
Operating Cash FlowLast quarter
$122.5M
Free Cash FlowOCF − Capex
$104.6M
FCF MarginFCF / Revenue
11.2%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
ST
ST
Q1 26
$122.5M
Q4 25
$294.0M
$201.5M
Q3 25
$659.9M
$159.9M
Q2 25
$303.0M
$140.9M
Q1 25
$183.8M
$119.2M
Q4 24
$301.4M
$170.7M
Q3 24
$199.5M
$130.9M
Q2 24
$279.4M
$143.5M
Free Cash Flow
DXCM
DXCM
ST
ST
Q1 26
$104.6M
Q4 25
$192.1M
$151.9M
Q3 25
$579.4M
$136.2M
Q2 25
$208.9M
$115.5M
Q1 25
$96.8M
$86.6M
Q4 24
$176.8M
$138.9M
Q3 24
$88.3M
$91.3M
Q2 24
$213.3M
$98.4M
FCF Margin
DXCM
DXCM
ST
ST
Q1 26
11.2%
Q4 25
15.3%
16.6%
Q3 25
47.9%
14.6%
Q2 25
18.1%
12.2%
Q1 25
9.3%
9.5%
Q4 24
15.9%
15.3%
Q3 24
8.9%
9.3%
Q2 24
21.2%
9.5%
Capex Intensity
DXCM
DXCM
ST
ST
Q1 26
Q4 25
8.1%
5.4%
Q3 25
6.7%
2.5%
Q2 25
8.1%
2.7%
Q1 25
8.4%
3.6%
Q4 24
11.2%
3.5%
Q3 24
11.2%
4.0%
Q2 24
6.6%
4.4%
Cash Conversion
DXCM
DXCM
ST
ST
Q1 26
1.41×
Q4 25
1.10×
3.19×
Q3 25
2.33×
Q2 25
1.69×
2.32×
Q1 25
1.74×
1.70×
Q4 24
1.99×
29.50×
Q3 24
1.48×
Q2 24
1.95×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons